India has been ranked 19th among 28 nations in the Biopharmaceutical Competitiveness Survey, commissioned by the Pharmaceutical Research and Manufacturers of America. Countries were graded on scientific capabilities and infrastructure, clinical research conditions and framework, regulatory system, market access and financing, and effective intellectual property protections. The US topped the list.